ProfileGDS4718 / 1555998_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 71% 69% 64% 71% 72% 64% 63% 70% 70% 71% 69% 72% 67% 61% 61% 67% 67% 63% 66% 67% 71% 65% 67% 72% 68% 62% 76% 68% 70% 66% 65% 64% 70% 68% 67% 63% 65% 68% 70% 61% 70% 64% 67% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.9588971
GSM549102patient 115, normal, homogenized [OPG study]6.7761469
GSM549104patient 119, normal, homogenized [OPG study]6.4040864
GSM549108patient 138, normal, homogenized [OPG study]6.9546171
GSM549119patient 077, normal, homogenized [OPG study]6.9822272
GSM549133patient 032, cancer, homogenized [OPG study]6.4440664
GSM549139patient 042, cancer, homogenized [OPG study]6.3619763
GSM549099patient 107, normal, homogenized [OPG study]6.8295370
GSM549109patient 139, normal, homogenized [OPG study]6.8248570
GSM549110patient 046, normal, homogenized [OPG study]6.8872971
GSM549114patient 063, normal, homogenized [OPG study]6.7495669
GSM549122patient 082, normal, homogenized [OPG study]7.0995572
GSM549134patient 033, cancer, homogenized [OPG study]6.6384267
GSM549136patient 036, cancer, homogenized [OPG study]6.1991761
GSM549140patient 044, cancer, homogenized [OPG study]6.1909661
GSM549111patient 047, normal, homogenized [OPG study]6.6571667
GSM549113patient 057, normal, homogenized [OPG study]6.6002867
GSM549132patient 031, cancer, homogenized [OPG study]6.3678963
GSM549137patient 038, cancer, homogenized [OPG study]6.5986466
GSM549142patient 047, cancer, homogenized [OPG study]6.6772267
GSM549100patient 110, normal, homogenized [OPG study]6.894471
GSM549107patient 135, normal, homogenized [OPG study]6.4727665
GSM549115patient 068, normal, homogenized [OPG study]6.6252767
GSM549116patient 072, normal, homogenized [OPG study]7.1087172
GSM549120patient 078, normal, homogenized [OPG study]6.7203768
GSM549131patient 030, cancer, homogenized [OPG study]6.2558762
GSM549118patient 074, normal, homogenized [OPG study]7.4042976
GSM549129patient 027, cancer, homogenized [OPG study]6.7591268
GSM549123patient 088, normal, homogenized [OPG study]6.8723470
GSM549124patient 006, cancer, homogenized [OPG study]6.530466
GSM549126patient 015, cancer, homogenized [OPG study]6.4498365
GSM549128patient 025, cancer, homogenized [OPG study]6.4127864
GSM549103patient 117, normal, homogenized [OPG study]6.8350570
GSM549117patient 073, normal, homogenized [OPG study]6.6773868
GSM549138patient 041, cancer, homogenized [OPG study]6.6533167
GSM549141patient 045, cancer, homogenized [OPG study]6.3407563
GSM549130patient 028, cancer, homogenized [OPG study]6.4827465
GSM549101patient 111, normal, homogenized [OPG study]6.7542168
GSM549105patient 128, normal, homogenized [OPG study]6.8771570
GSM549106patient 134, normal, homogenized [OPG study]6.2027961
GSM549112patient 048, normal, homogenized [OPG study]6.9000570
GSM549125patient 011, cancer, homogenized [OPG study]6.4003764
GSM549127patient 024, cancer, homogenized [OPG study]6.6932267
GSM549135patient 035, cancer, homogenized [OPG study]6.4650865